Metabolic syndrome and prevalence in an urban, medically underserved, community-based population

John Ryan, Cheryl Brewster, Peter Demaria, Mark Fedders, Terri Jennings

Research output: Contribution to journalArticle

Abstract

Problem: The metabolic syndrome is a constellation of risk factors thought to indicate increased risk for type 2 diabetes (T2DM) and cardiovascular disease (CVD). Clinical utility of the metabolic syndrome lies in identifying patients at risk of T2DM and CVD and motivating them to reduce underlying risks. However, there appears to be a paradoxical difference in the incidence and prevalence of the metabolic syndrome when comparing African Americans to other population groups. This study is meant to examine capability of detecting metabolic syndrome among minority individuals in a community-based sample. Methods: Relevant measures were collected from 107 community-members at a community-based event. Means for measures were calculated, as were estimates of the sample likely to have metabolic syndrome based on ATP-III criteria. Results: Participants had a mean age of 49.5 years. Various proportions of the sample reflected components of the metabolic syndrome using ATP-III criteria, including high blood pressure (59.6%), elevated waist circumference (49.3%), elevated triglyceride levels (33.7%), elevated fasting blood glucose levels (28.6%) and reduced HDL-C (26.7%). Prevalence of metabolic syndrome was considered for 71 (66.35%) of the sample with adequate data; 28.17% presented with three or more of the ATP-III components. Conclusions: There is a need for a primary prevention intervention among minority community-members. An intensive lifestyle intervention to address all of the metabolic risk factors simultaneously, including an atherogenic diet, weight loss, increased physical activity and smoking cessation is preferable rather than only pharmacologic treatment.

Original languageEnglish
Pages (from-to)137-142
Number of pages6
JournalDiabetes and Metabolic Syndrome: Clinical Research and Reviews
Volume4
Issue number3
DOIs
StatePublished - Jul 1 2010

Fingerprint

Population
Adenosine Triphosphate
Cardiovascular Diseases
Atherogenic Diet
Waist Circumference
Smoking Cessation
Primary Prevention
Population Groups
African Americans
Type 2 Diabetes Mellitus
Blood Glucose
Life Style
Weight Loss
Fasting
Triglycerides
Exercise
Hypertension
Incidence
Therapeutics

Keywords

  • African American
  • Cardiovascular disease
  • Metabolic syndrome
  • Type 2 diabetes mellitus

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Internal Medicine

Cite this

Metabolic syndrome and prevalence in an urban, medically underserved, community-based population. / Ryan, John; Brewster, Cheryl; Demaria, Peter; Fedders, Mark; Jennings, Terri.

In: Diabetes and Metabolic Syndrome: Clinical Research and Reviews, Vol. 4, No. 3, 01.07.2010, p. 137-142.

Research output: Contribution to journalArticle

Ryan, John ; Brewster, Cheryl ; Demaria, Peter ; Fedders, Mark ; Jennings, Terri. / Metabolic syndrome and prevalence in an urban, medically underserved, community-based population. In: Diabetes and Metabolic Syndrome: Clinical Research and Reviews. 2010 ; Vol. 4, No. 3. pp. 137-142.
@article{f4d279e624eb476396865d5f6c3c3392,
title = "Metabolic syndrome and prevalence in an urban, medically underserved, community-based population",
abstract = "Problem: The metabolic syndrome is a constellation of risk factors thought to indicate increased risk for type 2 diabetes (T2DM) and cardiovascular disease (CVD). Clinical utility of the metabolic syndrome lies in identifying patients at risk of T2DM and CVD and motivating them to reduce underlying risks. However, there appears to be a paradoxical difference in the incidence and prevalence of the metabolic syndrome when comparing African Americans to other population groups. This study is meant to examine capability of detecting metabolic syndrome among minority individuals in a community-based sample. Methods: Relevant measures were collected from 107 community-members at a community-based event. Means for measures were calculated, as were estimates of the sample likely to have metabolic syndrome based on ATP-III criteria. Results: Participants had a mean age of 49.5 years. Various proportions of the sample reflected components of the metabolic syndrome using ATP-III criteria, including high blood pressure (59.6{\%}), elevated waist circumference (49.3{\%}), elevated triglyceride levels (33.7{\%}), elevated fasting blood glucose levels (28.6{\%}) and reduced HDL-C (26.7{\%}). Prevalence of metabolic syndrome was considered for 71 (66.35{\%}) of the sample with adequate data; 28.17{\%} presented with three or more of the ATP-III components. Conclusions: There is a need for a primary prevention intervention among minority community-members. An intensive lifestyle intervention to address all of the metabolic risk factors simultaneously, including an atherogenic diet, weight loss, increased physical activity and smoking cessation is preferable rather than only pharmacologic treatment.",
keywords = "African American, Cardiovascular disease, Metabolic syndrome, Type 2 diabetes mellitus",
author = "John Ryan and Cheryl Brewster and Peter Demaria and Mark Fedders and Terri Jennings",
year = "2010",
month = "7",
day = "1",
doi = "10.1016/j.dsx.2010.07.002",
language = "English",
volume = "4",
pages = "137--142",
journal = "Diabetes and Metabolic Syndrome: Clinical Research and Reviews",
issn = "1871-4021",
publisher = "Elsevier BV",
number = "3",

}

TY - JOUR

T1 - Metabolic syndrome and prevalence in an urban, medically underserved, community-based population

AU - Ryan, John

AU - Brewster, Cheryl

AU - Demaria, Peter

AU - Fedders, Mark

AU - Jennings, Terri

PY - 2010/7/1

Y1 - 2010/7/1

N2 - Problem: The metabolic syndrome is a constellation of risk factors thought to indicate increased risk for type 2 diabetes (T2DM) and cardiovascular disease (CVD). Clinical utility of the metabolic syndrome lies in identifying patients at risk of T2DM and CVD and motivating them to reduce underlying risks. However, there appears to be a paradoxical difference in the incidence and prevalence of the metabolic syndrome when comparing African Americans to other population groups. This study is meant to examine capability of detecting metabolic syndrome among minority individuals in a community-based sample. Methods: Relevant measures were collected from 107 community-members at a community-based event. Means for measures were calculated, as were estimates of the sample likely to have metabolic syndrome based on ATP-III criteria. Results: Participants had a mean age of 49.5 years. Various proportions of the sample reflected components of the metabolic syndrome using ATP-III criteria, including high blood pressure (59.6%), elevated waist circumference (49.3%), elevated triglyceride levels (33.7%), elevated fasting blood glucose levels (28.6%) and reduced HDL-C (26.7%). Prevalence of metabolic syndrome was considered for 71 (66.35%) of the sample with adequate data; 28.17% presented with three or more of the ATP-III components. Conclusions: There is a need for a primary prevention intervention among minority community-members. An intensive lifestyle intervention to address all of the metabolic risk factors simultaneously, including an atherogenic diet, weight loss, increased physical activity and smoking cessation is preferable rather than only pharmacologic treatment.

AB - Problem: The metabolic syndrome is a constellation of risk factors thought to indicate increased risk for type 2 diabetes (T2DM) and cardiovascular disease (CVD). Clinical utility of the metabolic syndrome lies in identifying patients at risk of T2DM and CVD and motivating them to reduce underlying risks. However, there appears to be a paradoxical difference in the incidence and prevalence of the metabolic syndrome when comparing African Americans to other population groups. This study is meant to examine capability of detecting metabolic syndrome among minority individuals in a community-based sample. Methods: Relevant measures were collected from 107 community-members at a community-based event. Means for measures were calculated, as were estimates of the sample likely to have metabolic syndrome based on ATP-III criteria. Results: Participants had a mean age of 49.5 years. Various proportions of the sample reflected components of the metabolic syndrome using ATP-III criteria, including high blood pressure (59.6%), elevated waist circumference (49.3%), elevated triglyceride levels (33.7%), elevated fasting blood glucose levels (28.6%) and reduced HDL-C (26.7%). Prevalence of metabolic syndrome was considered for 71 (66.35%) of the sample with adequate data; 28.17% presented with three or more of the ATP-III components. Conclusions: There is a need for a primary prevention intervention among minority community-members. An intensive lifestyle intervention to address all of the metabolic risk factors simultaneously, including an atherogenic diet, weight loss, increased physical activity and smoking cessation is preferable rather than only pharmacologic treatment.

KW - African American

KW - Cardiovascular disease

KW - Metabolic syndrome

KW - Type 2 diabetes mellitus

UR - http://www.scopus.com/inward/record.url?scp=77956186834&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956186834&partnerID=8YFLogxK

U2 - 10.1016/j.dsx.2010.07.002

DO - 10.1016/j.dsx.2010.07.002

M3 - Article

AN - SCOPUS:77956186834

VL - 4

SP - 137

EP - 142

JO - Diabetes and Metabolic Syndrome: Clinical Research and Reviews

JF - Diabetes and Metabolic Syndrome: Clinical Research and Reviews

SN - 1871-4021

IS - 3

ER -